» Articles » PMID: 28911711

Effects of Aqueous Extract of Ruta Graveolens and Its Ingredients on Cytochrome P450, Uridine Diphosphate (UDP)-glucuronosyltransferase, and Reduced Nicotinamide Adenine Dinucleotide (phosphate) (NAD(P)H)-quinone Oxidoreductase in Mice

Overview
Date 2017 Sep 16
PMID 28911711
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Ruta graveolens (the common rue) has been used for various therapeutic purposes, including relief of rheumatism and treatment of circulatory disorder. To elucidate the effects of rue on main drug-metabolizing enzymes, effects of an aqueous extract of the aerial part of rue and its ingredients on cytochrome P450 (P450/CYP), uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H):quinone oxidoreductase were studied in C57BL/6JNarl mice. Oral administration of rue extract to males increased hepatic Cyp1a and Cyp2b activities in a dose-dependent manner. Under a 7-day treatment regimen, rue extract (0.5 g/kg) induced hepatic Cyp1a and Cyp2b activities and protein levels in males and females. This treatment increased hepatic UDP-glucuronosyltransferase activity only in males. However, NAD(P)H:quinone oxidoreductase activity remained unchanged. Based on the contents of rutin and furanocoumarins of mouse dose of rue extract, rutin increased hepatic Cyp1a activity and the mixture of furanocoumarins (F) increased Cyp2b activities in males. The mixture of rutin and F increased Cyp1a and Cyp2b activities. These results revealed that rutin and F contributed at least in part to the P450 induction by rue.

Citing Articles

Traditional Uses, Phytochemistry, Pharmacology and Toxicology of : A Critical Review and Future Perspectives.

Luo P, Feng X, Liu S, Jiang Y Drug Des Devel Ther. 2025; 18:6459-6485.

PMID: 39758226 PMC: 11697671. DOI: 10.2147/DDDT.S494417.


Dietary Intake of Coumarins and Furocoumarins through Citrus Beverages: A Detailed Estimation by a HPLC-MS/MS Method Combined with the Linear Retention Index System.

Arigo A, Rigano F, Russo M, Trovato E, Dugo P, Mondello L Foods. 2021; 10(7).

PMID: 34359404 PMC: 8303230. DOI: 10.3390/foods10071533.


Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential.

Nahar L, Al-Majmaie S, Al-Groshi A, Rasul A, Sarker S Molecules. 2021; 26(6).

PMID: 33799365 PMC: 7999183. DOI: 10.3390/molecules26061609.


The time-dependent effects of St John's wort on cytochrome P450, uridine diphosphate-glucuronosyltransferase, glutathione S-transferase, and NAD(P)H-quinone oxidoreductase in mice.

Yang J, Liu Y, Huang C, Ueng Y J Food Drug Anal. 2018; 26(1):422-431.

PMID: 29389584 PMC: 9332643. DOI: 10.1016/j.jfda.2017.01.004.

References
1.
Gelboin H . Cytochrome P450 and monoclonal antibodies. Pharmacol Rev. 1993; 45(4):413-53. View

2.
Lubet R, Mayer R, CAMERON J, Nims R, Burke M, Wolff T . Dealkylation of pentoxyresorufin: a rapid and sensitive assay for measuring induction of cytochrome(s) P-450 by phenobarbital and other xenobiotics in the rat. Arch Biochem Biophys. 1985; 238(1):43-8. DOI: 10.1016/0003-9861(85)90138-9. View

3.
Ueng Y, Chen C, Yamazaki H, Kiyotani K, Chang Y, Lo W . Mechanism-based inhibition of CYP1A1 and CYP3A4 by the furanocoumarin chalepensin. Drug Metab Pharmacokinet. 2012; 28(3):229-38. DOI: 10.2133/dmpk.dmpk-12-rg-113. View

4.
Kerry N, Somogyi A, Mikus G, Bochner F . Primary and secondary oxidative metabolism of dextromethorphan. In vitro studies with female Sprague-Dawley and Dark Agouti rat liver microsomes. Biochem Pharmacol. 1993; 45(4):833-9. DOI: 10.1016/0006-2952(93)90166-t. View

5.
Yang J, Qian D, Jiang S, Shang E, Guo J, Duan J . Identification of rutin deglycosylated metabolites produced by human intestinal bacteria using UPLC-Q-TOF/MS. J Chromatogr B Analyt Technol Biomed Life Sci. 2012; 898:95-100. DOI: 10.1016/j.jchromb.2012.04.024. View